NovoTTF: where to go from here?
作者信息
Cloughesy Timothy F, Lassman Andrew B
机构信息
UCLA Neuro-Oncology Program and Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, USA.
出版信息
Neuro Oncol. 2017 May 1;19(5):605-608. doi: 10.1093/neuonc/nox014.
Abstract
摘要
相似文献
1
NovoTTF: where to go from here?新型肿瘤治疗电场（NovoTTF）：何去何从？
Neuro Oncol. 2017 May 1;19(5):605-608. doi: 10.1093/neuonc/nox014.
2
Characterization and management of dermatologic adverse events with the NovoTTF-100A System, a novel anti-mitotic electric field device for the treatment of recurrent glioblastoma.新型抗有丝分裂电场仪 NovoTTF-100A 系统治疗复发性脑胶质瘤的皮肤不良事件的特征与处理。
Semin Oncol. 2014 Jun;41 Suppl 4:S1-14. doi: 10.1053/j.seminoncol.2014.03.011. Epub 2014 Mar 19.
3
Delayed response and survival from NovoTTF-100A in recurrent GBM.复发性 GBM 患者应用 NovoTTF-100A 后反应延迟和生存时间延长。
Med Oncol. 2013 Mar;30(1):338. doi: 10.1007/s12032-012-0338-1. Epub 2013 Jan 10.
4
NovoTTF-100A: a new treatment modality for recurrent glioblastoma.NovoTTF-100A：复发性脑胶质瘤的一种新治疗方式。
Expert Rev Neurother. 2012 Aug;12(8):895-9. doi: 10.1586/ern.12.80. Epub 2012 Jun 19.
5
A roundtable discussion on the clinical challenges and options for the treatment of glioblastoma: introducing a novel modality, TTFields.关于胶质母细胞瘤治疗的临床挑战和选择的圆桌讨论：引入一种新的模式，TTFields。
Semin Oncol. 2013 Dec;40(6):S2-4. doi: 10.1053/j.seminoncol.2013.10.002. Epub 2013 Oct 10.
6
Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe).用于胶质母细胞瘤的NovoTTF-100A™系统的临床实践经验：患者登记数据集（PRiDe）
Semin Oncol. 2014 Oct;41 Suppl 6:S4-S13. doi: 10.1053/j.seminoncol.2014.09.010. Epub 2014 Sep 16.
7
Tumor Treating Fields in Neuro-Oncological Practice.神经肿瘤学实践中的肿瘤治疗电场
Curr Oncol Rep. 2017 Aug;19(8):53. doi: 10.1007/s11912-017-0611-8.
8
The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system.场强对接受NovoTTF™-100A系统治疗的多形性胶质母细胞瘤患者反应的影响。
World J Surg Oncol. 2014 May 22;12:162. doi: 10.1186/1477-7819-12-162.
9
First-in-class antimitotic device approved for glioblastoma.
Oncology (Williston Park). 2011 May;25(6):546.
10
Post Hoc analyses of intention-to-treat population in phase III comparison of NovoTTF-100A™ system versus best physician's choice chemotherapy.在NovoTTF-100A™系统与最佳医生选择化疗的III期比较中对意向性治疗人群进行的事后分析。
Semin Oncol. 2014 Oct;41 Suppl 6:S25-34. doi: 10.1053/j.seminoncol.2014.09.008. Epub 2014 Sep 16.
引用本文的文献
1
Glioblastoma and Immune Checkpoint Inhibitors: A Glance at Available Treatment Options and Future Directions.胶质母细胞瘤与免疫检查点抑制剂：现有治疗方案及未来方向概览。
Int J Mol Sci. 2024 Oct 7;25(19):10765. doi: 10.3390/ijms251910765.
2
Gene Expression Patterns Associated with Survival in Glioblastoma.与胶质母细胞瘤患者生存相关的基因表达模式。
Int J Mol Sci. 2024 Mar 25;25(7):3668. doi: 10.3390/ijms25073668.
3
Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives.胶质母细胞瘤治疗的免疫治疗策略：当前挑战与未来展望
Cancers (Basel). 2024 Mar 25;16(7):1276. doi: 10.3390/cancers16071276.
4
Medical Device Advances in the Treatment of Glioblastoma.胶质母细胞瘤治疗中的医疗设备进展
Cancers (Basel). 2022 Oct 29;14(21):5341. doi: 10.3390/cancers14215341.
5
Updates in IDH-Wildtype Glioblastoma.IDH 野生型胶质母细胞瘤的最新进展。
Neurotherapeutics. 2022 Oct;19(6):1705-1723. doi: 10.1007/s13311-022-01251-6. Epub 2022 May 31.
6
Expression Levels of RAD51 Inversely Correlate with Survival of Glioblastoma Patients.RAD51的表达水平与胶质母细胞瘤患者的生存率呈负相关。
Cancers (Basel). 2021 Oct 26;13(21):5358. doi: 10.3390/cancers13215358.
7
Tumor-Treating Fields for the treatment of glioblastoma: a systematic review and meta-analysis.用于治疗胶质母细胞瘤的肿瘤治疗电场：一项系统评价和荟萃分析。
Neurooncol Pract. 2021 Apr 20;8(4):426-440. doi: 10.1093/nop/npab026. eCollection 2021 Aug.
8
Current usage of tumor treating fields for glioblastoma.胶质母细胞瘤的肿瘤治疗电场当前应用情况。
Neurooncol Adv. 2020 Jun 4;2(1):vdaa069. doi: 10.1093/noajnl/vdaa069. eCollection 2020 Jan-Dec.
9
Integration of Tumor-Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies.肿瘤电场治疗与实体瘤患者多学科综合管理的整合。
Oncologist. 2019 Dec;24(12):e1426-e1436. doi: 10.1634/theoncologist.2017-0603. Epub 2019 Aug 23.
10
Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial.电场治疗对新诊断胶质母细胞瘤患者健康相关生活质量的影响：一项随机临床试验的二次分析。
JAMA Oncol. 2018 Apr 1;4(4):495-504. doi: 10.1001/jamaoncol.2017.5082.
本文引用的文献
1
The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma.肿瘤电场治疗在新诊断胶质母细胞瘤患者中的成本效益
Neuro Oncol. 2016 Aug;18(8):1129-36. doi: 10.1093/neuonc/now102. Epub 2016 May 13.
2
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.替莫唑胺联合肿瘤电场治疗与替莫唑胺单药治疗胶质母细胞瘤的维持治疗：一项随机临床试验。
JAMA. 2015 Dec 15;314(23):2535-43. doi: 10.1001/jama.2015.16669.
3
Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter--still a dilemma?胶质母细胞瘤患者中，若其O⁶-甲基鸟嘌呤-DNA甲基转移酶（MGMT）启动子未甲基化，是否停用替莫唑胺——这仍是一个两难问题？
Neuro Oncol. 2015 Nov;17(11):1425-7. doi: 10.1093/neuonc/nov198. Epub 2015 Sep 15.
4
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.NovoTTF-100A 与医师选择化疗治疗复发性胶质母细胞瘤的比较：一种新型治疗方式的随机 III 期试验。
Eur J Cancer. 2012 Sep;48(14):2192-202. doi: 10.1016/j.ejca.2012.04.011. Epub 2012 May 18.
5
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.同步放化疗联合辅助替莫唑胺与单纯放疗对胶质母细胞瘤生存影响的随机III期研究：EORTC-NCIC试验的5年分析
Lancet Oncol. 2009 May;10(5):459-66. doi: 10.1016/S1470-2045(09)70025-7. Epub 2009 Mar 9.
6
Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial.用于恶性胶质瘤初次手术的Gliadel薄片：一项多中心对照试验的长期随访
Acta Neurochir (Wien). 2006 Mar;148(3):269-75; discussion 275. doi: 10.1007/s00701-005-0707-z. Epub 2006 Feb 17.
7
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.卡氮芥和/或放疗治疗间变性胶质瘤的评估。一项合作临床试验。
J Neurosurg. 1978 Sep;49(3):333-43. doi: 10.3171/jns.1978.49.3.0333.
Zotero 插件